GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Cyclically Adjusted PB Ratio

Rhinomed (ASX:RNO) Cyclically Adjusted PB Ratio : 0.57 (As of Apr. 27, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Rhinomed Cyclically Adjusted PB Ratio?

As of today (2024-04-27), Rhinomed's current share price is A$0.04. Rhinomed's Cyclically Adjusted Book per Share for the fiscal year that ended in Jun23 was A$0.07. Rhinomed's Cyclically Adjusted PB Ratio for today is 0.57.

The historical rank and industry rank for Rhinomed's Cyclically Adjusted PB Ratio or its related term are showing as below:

ASX:RNO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.19   Med: 0.51   Max: 2.11
Current: 0.59

During the past 13 years, Rhinomed's highest Cyclically Adjusted PB Ratio was 2.11. The lowest was 0.19. And the median was 0.51.

ASX:RNO's Cyclically Adjusted PB Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.11 vs ASX:RNO: 0.59

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Rhinomed's adjusted book value per share data of for the fiscal year that ended in Jun23 was A$-0.022. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is A$0.07 for the trailing ten years ended in Jun23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Rhinomed Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Rhinomed's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhinomed Cyclically Adjusted PB Ratio Chart

Rhinomed Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 0.19 0.74 1.29 1.04

Rhinomed Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 - 1.29 - 1.04

Competitive Comparison of Rhinomed's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Rhinomed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhinomed's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rhinomed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Rhinomed's Cyclically Adjusted PB Ratio falls into.



Rhinomed Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Rhinomed's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.04/0.07
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhinomed's Cyclically Adjusted Book per Share for the fiscal year that ended in Jun23 is calculated as:

For example, Rhinomed's adjusted Book Value per Share data for the fiscal year that ended in Jun23 was:

Adj_Book=Book Value per Share/CPI of Jun23 (Change)*Current CPI (Jun23)
=-0.022/124.1700*124.1700
=-0.022

Current CPI (Jun23) = 124.1700.

Rhinomed Annual Data

Book Value per Share CPI Adj_Book
201406 0.165 98.352 0.208
201506 0.110 99.838 0.137
201606 0.087 100.859 0.107
201706 0.057 102.809 0.069
201806 0.040 104.945 0.047
201906 0.032 106.617 0.037
202006 0.042 106.246 0.049
202106 0.019 110.332 0.021
202206 0.018 117.112 0.019
202306 -0.022 124.170 -0.022

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Rhinomed  (ASX:RNO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Rhinomed Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Rhinomed's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhinomed (ASX:RNO) Business Description

Traded in Other Exchanges
Address
132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121
Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Rhinomed (ASX:RNO) Headlines

No Headlines